Acne vulgaris is a common disease that can lead to challenges in many areas of personal life. There are numerous treatment options currently available, but many require administration for at least six to eight weeks before benefits are observed. Existing treatments for acne are either topical or systemic and include benzoyl peroxide, retinoids, salicylic acid, antibiotics, hormone treatments, and Isotretinoin™. New therapies are needed that are both effective and well tolerated by patients. Recently, lasers and nonlaser light sources have shown promise in the treatment of common acne.
Early inflammatory acne lesions are characterized by the infiltration of the pilosebaceous duct with T-cells that are reactive to P. acnes. The association of the cells and the acnes yields inflammatory acne. P. acnes is the organism that can be killed through exposure to certain wavelengths of light. This concept is similar to that of exposure to sunlight, which serves as the original source of the theory of light treatment.
Lewis P. Stolman, M.D.
Dermatology and Laser Center
of New Jersey
Livingston, New Jersey
To Download the Complete Clinical Bulletin Vbeam® Treatment of Inflammatory Acne Vulgaris, click here.